E-mail this page Printer Friendly Version RSS E-mail Alerts View contacts Download Financial Tear Sheet 

2017 Press Releases

This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
DateTitle 
04/24/17Quest Diagnostics 50th Anniversary: Celebrating a Half Century of Life-Changing Results
To mark the milestone, Quest provides charitable grants of $50,000 each to the American Red Cross, the National Ovarian Cancer Coalition and Autism Speaks MADISON, N.J., April 24, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, commemorated its 50-year anniversary by awarding $150,000 in total grants to three organizations that share its goal to improve healthcare: The American Red Cross, the National Ovarian Cancer Coalit... 
Printer Friendly Version
04/20/17Quest Diagnostics Reports First Quarter 2017 Financial Results, Raises 2017 Financial Outlook
- First quarter revenues of $1.90 billion, up 1.9% on a reported basis and up 3.0% on an equivalent basis versus 2016 - First quarter diluted EPS of $1.16 on a reported basis, up 63.4% from 2016; and $1.33 on an adjusted basis excluding amortization, up 17.7% from 2016. Excess tax benefit associated with stock-based compensation increased diluted earnings per share by $0.11 in the quarter. - Raises outlook for full year 2017 diluted EPS. Reported diluted EPS now expected to be between $4.7... 
Printer Friendly Version
04/07/17Quest Diagnostics To Release First Quarter 2017 Financial Results On April 20
MADISON, N.J., April 7, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report first quarter 2017 results on Thursday, April 20, 2017, before the market opens.  It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by dialing 888-300-0211 ... 
Printer Friendly Version
04/06/17Quest Diagnostics Presents Supplier Excellence Awards to Five Partners
MADISON, N.J., April 6, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today awarded Supplier Excellence Awards to five companies at its 2017 Supplier Forum. Supplier Excellence awards recognize world class products, systems, or services that provide consistent and reliable performance; companies that develop and implement novel solutions to move the business forward; individuals who step u... 
Printer Friendly Version
03/07/17Quest Diagnostics To Speak At The Barclays Global Healthcare Conference
MADISON, N.J., March 7, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami. Stephen Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, March 15, 2017 at 8:30 a.m. Eastern Ti... 
Printer Friendly Version
03/06/17Quest Diagnostics and American Diabetes Association® to Help Identify People at Risk for Type 2 Diabetes
Quest Diagnostics will donate up to $200,000 to American Diabetes Association -- $1 for every employee biometric wellness screening it completes between March 28 and April 27 MADISON, N.J., March 6, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, including employer health and wellness screening and health improvement services, announced a unique collaboration with the American Diabetes Association aimed at helping more peo... 
Printer Friendly Version
02/21/17Quest Diagnostics Declares Quarterly Cash Dividend
MADISON, N.J., Feb.  21, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share, payable on April 19, 2017 to shareholders of record of Quest Diagnostics common stock on April 5, 2017. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes.  Derived from th... 
Printer Friendly Version
02/16/17Quest Diagnostics: Harvard Pilgrim Health Care Partners with Physicians to Close Costly Gaps in Care
Physicians to use health analytics technology Data Diagnostics® from Quest Diagnostics and Inovalon to help improve patient care and financial performance MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Harvard Pilgrim Health Care now offers physicians Data Diagnostics®, a point-of-care health analytics technology from Quest Diagnostics (NYSE: DGX) and Inovalon (NASDAQ: INOV) that is designed to help close costly gaps in care and improve health outcomes. Ac... 
Printer Friendly Version
02/16/17Quest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine
MADISON, N.J., Feb. 16, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been named one of the "World's Most Admired Companies" for 2017 by Fortune.  The annual survey designated Quest Diagnostics as one of only six companies in the "Health Care: Pharmacy and Other Services" industry to attain Most Admired status, and the only diagnostic information services compan... 
Printer Friendly Version
02/15/17Quest Diagnostics and PeaceHealth to Increase Access to Innovative, High-Value Laboratory Services in the Pacific Northwest
Quest to acquire PeaceHealth Laboratories' outreach lab services and assume management of labs located within PeaceHealth's medical centers in three states MADISON, N.J. and VANCOUVER, Wash., Feb. 15, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and PeaceHealth, a mission-based not-for-profit healthcare system, have formed a two-part arrangement to enhance the delivery of laboratory services to communities in Oregon, Wa... 
Printer Friendly Version
02/08/17Veracyte To Expand Patient Access To The Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement With Quest Diagnostics
SOUTH SAN FRANCISCO, Calif., Feb. 8, 2017 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic uncertainty, will extend access to its Afirma Gene Expression Classifier (GEC) through an agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services. The agreement is intended to meet growing physician demand for innovative genomic testing ser... 
Printer Friendly Version
01/26/17Quest Diagnostics Reports Fourth Quarter And Full Year 2016 Financial Results; Provides Guidance For Full Year 2017
-- Fourth quarter revenues of $1.86 billion, up 0.7% on a reported basis and up 1.9% on an equivalent basis versus 2015 -- Fourth quarter diluted EPS of $1.09 on a reported basis, down 15.5% from 2015; fourth quarter diluted EPS of $1.31 on an adjusted basis excluding amortization, up 10.1% from 2015 -- Full year revenues of $7.52 billion, up 0.3% on a reported basis and up 2.6% on an equivalent basis versus 2015 -- Full year diluted EPS of $4.51 on a reported basis, down 7.4% from 2015... 
Printer Friendly Version
01/26/17Quest Diagnostics Partners With Montefiore Health System to Deliver High-Value, Innovative Laboratory Services
MADISON, N.J. and NEW YORK, Jan. 26, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, is working with  Montefiore Health System (MHS) to provide diagnostic laboratory services. This partnership will enhance the quality and efficiency of laboratory services at Montefiore. "We are pleased to partner with Montefiore, a premiere academic health system recognized for personalized, accountable car... 
Printer Friendly Version
01/18/17Quest Diagnostics Launches Nation's First Hepatitis B Virus Quantitative Test to Help Assess Response to Antiviral Therapy
Company expands hepatitis testing capabilities with new HBV surface antigen (sAg) quantitative testing MADISON, N.J., Jan. 18, 2017 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient's response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is sig... 
Printer Friendly Version
01/11/17Quest Diagnostics To Release Fourth Quarter And Full Year 2016 Financial Results On January 26
MADISON, N.J., Jan. 11, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2016 results on Thursday, January 26, 2017, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.  The conference call can be accessed in listen-only mode by diali... 
Printer Friendly Version
01/06/17Quest Diagnostics Achieves Perfect Score On 2017 Human Rights Campaign Corporate Equality Index
MADISON, N.J., Jan. 6, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, received a rating of 100 from the Human Rights Campaign Foundation on the 2017 Corporate Equality Index, earning the distinction of being a "Best Place to Work for LGBT Equality."  The Corporate Equality Index (CEI) is a national benchmarking survey and report on corporate policies and practices related to L... 
Printer Friendly Version
01/05/17Quest Diagnostics To Speak At The 35th Annual J.P. Morgan Healthcare Conference
MADISON, N.J., Jan. 5, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco. Steve Rusckowski, Chairman, President and CEO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, January 11, 2017 at 5:30 ... 
Printer Friendly Version